The Federal Trade Commission should use its rulemaking authority to address anticompetitive pharmaceutical industry practices like “rebate walls,” FTC Acting Chair Rebecca Slaughter and fellow Democratic commissioner Rohit Chopra urged in statements accompanying a commission report on rebate walls.
The FTC report, which was sent to Congress on 28 May, was requested by the US House as part...





